Email updates

Keep up to date with the latest news and content from BMC Pharmacology and Toxicology and BioMed Central.

This article is part of the supplement: 18th Scientific Symposium of the Austrian Pharmacological Society (APHAR)

Open Access Open Badges Meeting abstract

Herb-drug interactions: the influence of essential oil of caraway (Carum carvi L.) on the pharmacokinetics of paracetamol

Isidora Samojlik1*, Kornelia Ðaković-Švajcer1, Biljana Božin2 and Momir Mikov1

Author Affiliations

1 Department of Pharmacology and Toxicology, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia

2 Department of Pharmacy, Division of Pharmacognosy, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia

For all author emails, please log on.

BMC Pharmacology and Toxicology 2012, 13(Suppl 1):A27  doi:10.1186/2050-6511-13-S1-A27

The electronic version of this article is the complete one and can be found online at:

Published:17 September 2012

© 2012 Samojlik et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Despite the widespread use of herbal medicines, documented herb-drug interactions are sparse. Caraway (Carum carvi L.) is an aromatic plant from the Apiaceae family, widely used to flavor foods, as addition to fragrances, and for medical preparations. This survey examined the effects of chronic caraway essential oil pretreatment on paracetamol pharmacokinetics in male mice.


The essential oil (EO) of caraway, prepared as emulsion for peroral use, was applied to male mice during 5 consecutive days. Paracetamol, in the dose of 200 mg/kg, was applied p.o. or i.p. 2 hours after the last EO dose. Blood samples for pharmacokinetic assay were collected from the tail vein before paracetamol intake and 10, 30, 60, 90 and 120 min thereafter. Blood concentrations of paracetamol were determined by HPLC and the pharmacokinetic parameters were calculated using the WinNonlin software.


In the control group, pharmacokinetic parameters of paracetamol after p.o. and i.p. application were rather congruent. Caraway EO pretreatment induced a statistically significant augmentation of pharmacokinetic parameters (Cmax, AUC, AUC) of i.p. applied paracetamol, speaking in favor of enhanced body exposure to the drug. However, after p.o. application of paracetamol, the pharmacokinetic data showed a significant decrease compared to control values, indicating a decrease in drug presence in the organism.


The chronic intake of caraway EO influences the pharmacokinetic properties of both orally and intraperitoneally applied paracetamol. Further investigation of the exact pathway of this herb-drug interaction is needed, as well as the assessment of its real clinical significance.


This work was supported by grants no. TR23006 (coordinated by M. Mikov) and 172050 (coordinated by B. Škrbić) of the Ministry of Education and Science, Republic of Serbia.